Sign In

Christopher Ghadban

Principal at Alix Ventures, Advisor, and Strategy & Innovation Professional in the Life Sciences Sector

Christopher Ghadban is an entrepreneur and venture capitalist currently serving as an investor at The Venture Collective (TVC). He is dedicated to supporting early-stage startups, particularly those focused on deep technology and innovations that leverage biology to enhance human and planetary health. His work emphasizes the importance of frontier technologies in creating a more equitable future.3

Education and Background

Ghadban is an alumnus of The Wharton School, which is known for its strong emphasis on business and finance. His educational background has equipped him with the skills necessary to navigate the complexities of venture capital and entrepreneurship.1

Professional Experience

  • The Venture Collective (TVC): As an investor, Ghadban focuses on identifying and nurturing innovative startups that are at the forefront of technological advancement.
  • Alix Ventures: He also holds a position as Chief of Staff at Alix Ventures, where he engages in early seed financing and investment strategies.43

Interests and Contributions

Ghadban is passionate about fostering innovation in sectors that address significant global challenges. He frequently shares insights on investment trends and the evolving landscape of biotechnology through his social media platforms.25

Overall, Christopher Ghadban's work reflects a commitment to advancing technologies that promise substantial benefits for society.

Highlights

Mar 14 · linkedin

Fantastic news for patients! Truly exciting to witness the early and, hopefully continually, broadening array of options, and eagerly anticipating the development of corresponding diagnostics for the space

Oct 11 · linkedin

BIOS Builders 🧱 w/ Maddison Masaeli - Co-Founder & CEO @ Deepcell

Tune into our exciting discussion w/ Maddison as she gives insights about Deepcell's offering of an AI-powered imaging and microfluidics platform that identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics. Spun out of Stanford University in 2017, the company has created unique, microfluidics-based technology that uses continuously learning AI to classify cells based on detailed visual features and sort them without inherent bias.

Maddison Masaeli is a strong believer in the power of engineering to advance the world of life sciences and to accelerate biological discovery. She invented Deepcell’s AI-based single-cell analysis and sorting technology with her postdoctoral advisor Euan Ashley and Mahyar Salek, and spun the company out of Stanford University in 2017. Originally from Tehran, Iran, she has a multidisciplinary background with experience in electrical engineering, computer science, and bioengineering. Maddison holds a bachelor’s degree in electrical engineering from Sharif University of Technology, as well as a master’s degree in computer science and a PhD in bioengineering from the University of California, Los Angeles. She has published several papers in top-tier journals and has co-invented multiple patented technologies.

See our episode below... https://buff.ly/3LIIs9d

#DeepcellInnovation #AIinMedicine #MicrofluidicsTech #BiologicalDiscovery #LifeSciencesAdvancement #TranslationalResearch #DiagnosticTesting #Therapeutics #StanfordInnovation #BiotechInnovation #STEMAdvancement #CellAnalysisTech

Related Questions

What are some of the startups Christopher Ghadban has invested in at The Venture Collective?
How did Christopher Ghadban transition from Alix Ventures to The Venture Collective?
What are Christopher Ghadban's key interests in early-stage deep tech startups?
What role does Christopher Ghadban play at The Venture Collective?
Can you provide examples of frontier technologies Christopher Ghadban is passionate about?
Christopher Ghadban
Christopher Ghadban, photo 1
Christopher Ghadban, photo 2
Add to my network

Experience

Principal at Alix Ventures
Manager at BIOS (2021 - Present, United States), Creator at Biotech & Brews (2022 - Present, United States), Advisor at Nucleate (2021 - Present, Global), Startup Advisor at Ghadban Consulting (2012 - at Laudi's Breakfast House (January 2002 - August 2015)

Education

Master of Business Administration - MBA, Health Care Management at The Wharton School, Master of Science (MS), Bioengineering - Cell and Bioprocess Engineering at Tufts University, Bachelor of Science

Location

United States